These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3527984)

  • 1. Hormonal factors in vaginal candidiasis in rats.
    Kinsman OS; Collard AE
    Infect Immun; 1986 Sep; 53(3):498-504. PubMed ID: 3527984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of reproductive hormones on experimental vaginal candidiasis.
    Fidel PL; Cutright J; Steele C
    Infect Immun; 2000 Feb; 68(2):651-7. PubMed ID: 10639429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamentous growth and elevated vaginopathic potential of a nongerminative variant of Candida albicans expressing low virulence in systemic infection.
    De Bernardis F; Adriani D; Lorenzini R; Pontieri E; Carruba G; Cassone A
    Infect Immun; 1993 Apr; 61(4):1500-8. PubMed ID: 8454356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of progesterone on Candida albicans vaginal pathogenicity.
    Alves CT; Silva S; Pereira L; Williams DW; Azeredo J; Henriques M
    Int J Med Microbiol; 2014 Nov; 304(8):1011-7. PubMed ID: 25183575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ovarian steroids on vaginal smears in the rat.
    Montes GS; Luque EH
    Acta Anat (Basel); 1988; 133(3):192-9. PubMed ID: 3227778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental rat vaginal infection with Candida parapsilosis.
    De Bernardis F; Lorenzini R; Morelli L; Cassone A
    FEMS Microbiol Lett; 1989 Nov; 53(1-2):137-41. PubMed ID: 2612881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones modulate Candida vaginal isolates biofilm formation and decrease their susceptibility to azoles and hydrogen peroxide.
    Gonçalves B; Azevedo NM; Henriques M; Silva S
    Med Mycol; 2020 Apr; 58(3):341-350. PubMed ID: 31254346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical role of germ tube formation in the pathogenesis of candidal vaginitis.
    Sobel JD; Muller G; Buckley HR
    Infect Immun; 1984 Jun; 44(3):576-80. PubMed ID: 6327527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans: the estrogen target for vaginal colonization.
    Tarry W; Fisher M; Shen S; Mawhinney M
    J Surg Res; 2005 Dec; 129(2):278-82. PubMed ID: 16111702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of Candida vulvovaginitis.
    Sobel JD
    Curr Top Med Mycol; 1989; 3():86-108. PubMed ID: 2688924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of fibrinogen on Candida albicans germ tube formation.
    Rodrigues A; Vaz CP; Mårdh PA; da Fonseca AF; de Oliveira JM
    APMIS; 1999 Nov; 107(11):1020-2. PubMed ID: 10598874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Candida albicans with genital mucosa: effect of sex hormones on adherence of yeasts in vitro.
    Kalo A; Segal E
    Can J Microbiol; 1988 Mar; 34(3):224-8. PubMed ID: 3046721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to vaginal candidiasis under different conditions in mice.
    Tan J; Li J; Chen S; Wu Y; Qin FT; Ding J; Cao F; Zhang S
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):744-6. PubMed ID: 16696345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Absence of N-Acetyl-D-glucosamine Causes Attenuation of Virulence of Candida albicans upon Interaction with Vaginal Epithelial Cells In Vitro.
    Manczinger M; Bocsik A; Kocsis GF; Vörös A; Hegedűs Z; Ördögh L; Kondorosi É; Marton A; Vízler C; Tubak V; Deli M; Kemény L; Nagy I; Lakatos L
    Biomed Res Int; 2015; 2015():398045. PubMed ID: 26366412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis.
    Nohmi T; Abe S; Dobashi K; Tansho S; Yamaguchi H
    Microbiol Immunol; 1995; 39(6):405-9. PubMed ID: 8551972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new model of vaginal infection by Candida albicans in rats.
    Carrara MA; Donatti L; Damke E; Svidizinski TI; Consolaro ME; Batista MR
    Mycopathologia; 2010 Nov; 170(5):331-8. PubMed ID: 20532984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of Candida albicans by human vaginal epithelial cells.
    Barousse MM; Steele C; Dunlap K; Espinosa T; Boikov D; Sobel JD; Fidel PL
    J Infect Dis; 2001 Dec; 184(11):1489-93. PubMed ID: 11709796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis.
    De Bernardis F; Agatensi L; Ross IK; Emerson GW; Lorenzini R; Sullivan PA; Cassone A
    J Infect Dis; 1990 Jun; 161(6):1276-83. PubMed ID: 2189009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The yeast to hyphal transition following hematogenous candidiasis induces shock and organ injury independent of circulating tumor necrosis factor-alpha.
    Matuschak GM; Lechner AJ
    Crit Care Med; 1997 Jan; 25(1):111-20. PubMed ID: 8989186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen Receptor-Alpha (ESR1) Governs the Lower Female Reproductive Tract Vulnerability to
    Salinas-Muñoz L; Campos-Fernández R; Mercader E; Olivera-Valle I; Fernández-Pacheco C; Matilla L; García-Bordas J; Brazil JC; Parkos CA; Asensio F; Muñoz-Fernández MA; Hidalgo A; Sánchez-Mateos P; Samaniego R; Relloso M
    Front Immunol; 2018; 9():1033. PubMed ID: 29881378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.